Thermo Fisher Scientific Announces Launch of Immune Cell Types Family of Assays
Complete the form below to unlock access to ALL audio articles.
With the launch of the Applied Biosystems PureQuant Assays, Thermo Fisher Scientific has enhanced its industry-leading cell and gene therapy portfolio by providing an innovative method for identity and purity testing of cell-based therapeutics.
• Proven performance: The core technology has been used for identification and quantification of immune cell types for more than a decade.
• Easily standardized: The qPCR method enables consistent results across multiple users, instruments and sites.
• Facilitates regulatory filings: Regulatory support file provided upon request; established performance specifications following ICHQ2(R1) guidelines.
• Scheduling flexibility: The assay can be performed using fresh or frozen cells/gDNA.